SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

MARUSIć, Srdan; THALLER, Vlatko  y  JAVORNIK, Nenad. Psicofarmacoterapia en el tratamiento de los trastornos relacionados con el alcohol. Eur. J. Psychiat. (Ed. esp.) [online]. 2004, vol.18, n.4, pp.249-258. ISSN 1579-699X.

    ANTON, R.F. Pharmacologic approaches to the management of alcoholism. The Journal of Clinical Psychiatry, 62, 11-17, 2001. [ Links ]

    ANTON, R. What is craving? Models and implications for treatment. Alcohol Health and Research World, 23, 165-179, 1999. [ Links ]

    ANTON, R.F., DROBES, D.J. Clinical measurement of craving in addiction. Psychiatric Annals, 28, 553-560, 1998. [ Links ]

    ANTON, R.F., MOAK, D.H., LATHAM, P.K., et al. Post treatment results of combining naltrexone with cognitive-behavior therapy for the treatment of outpatient alcoholics. Journal of Clinical Psychopharmacology, 21, 72-77, 2001. [ Links ]

    BESSON, J., AEBY, F., KASA, A., LEHERT, P., POTGIETER, A. Combined efficacy of acamprosate and disulfiram in treatment of alcoholism: a controlled study. Alcoholism, Clinical and Experimental Research, 22, 573-579, 1998. [ Links ]

    CHICK, J., ANTON, R., CHECINSKI, K., et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism, 35, 587-593, 2000. [ Links ]

    FULLER RK., BRANCHEY, L., BRIGHTWELL, D.R., et al. Disulfiram treatment of alcoholism. The Journal of the American Medical Association, 256, 1449-1455, 1986. [ Links ]

    GALANTER, M., KLEBER, H.D. Textbook of Substance Abuse Treatment. 2nd ed. Arlington, Va: American Psychiatric Publishing, Inc., 1999. [ Links ]

    GEORGE, M.S., ANTON, R.F., BLOOMER, C., et al. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific sues. Archives of General Psychiatry, 58, 345-352, 2001. [ Links ]

    JOHNSON, B.A., AIT-DAOUD, N., PRIHODA, T.J. Combining ondasetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcoholism, Clinical and Experimental Research, 24, 737-742, 2000. [ Links ]

    JOHNSON, B.A., ROACHE, J.D., JAVORS, M.A., et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients. The Journal of the American Medical Association, 284, 963-971, 2000. [ Links ]

    KOOB, G.F., ROBERTS, A.J., SCHULTEIS, G., et al. Neurocircuitry targets in ethanol reward and dependence. Alcoholism, Clinical and Experimental Research, 22, 3-9, 1998. [ Links ]

    KRANZLER, H.R. Pharmacotherapy of alcoholism: Gaps in knowledge and opportunities for research. Alcohol and Alcoholism, 35, 537-547, 2000. [ Links ]

    KRYSTAL, J.H., CRAMER, J.S., KROL, W.F., et al. Naltrexone in treatment of alcohol dependence. The New England Journal of Medicine, 345, 734-1739, 2001. [ Links ]

    LEJOYEUX, M., ADES, J. Evalution of lithium treatment in alcoholism. Alcohol and Alcoholism, 28, 273-279, 1993. [ Links ]

    LEMARQUAND, D., PHIL, R.O., BENKELFAT, C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biological Psychology, 36, 395-421, 1994. [ Links ]

    LINNOILA, M., ECKARDT, M., DURCAN, M. Interactions of serotonin with ethanol: clinical animals studies. Psychopharmacology Bulletin, 23, 452-457, 1987. [ Links ]

    LITTLETON, J. Acamprosate in alcohol dependence: how does it work. Addiction, 90, 1179-1188, 1955. [ Links ]

    MACK, A.H., FRANKLIN, J.E., Jr., FRANCES, R.J. Concise Guide to Treatment of Alcoholism and addictions. 2nd ed. Arlington, VA: American Psychiatric Publishing, Inc., 2001. [ Links ]

    MALCOM, R., MYRICK, H., BRADY, K.T., BALLENGER, J.C. Update on anticonvalsants for treatment of alcohol withdrawal. The American Journal on Addictions, 10 (suppl), 16-23, 2001. [ Links ]

    MYRICK, H., BRADY, K.T., MALCOLM, R. New developments in pharmacotherapy of alcohol dependence. The American Journal on Addictions, 10 (suppl), 3-15, 2001. [ Links ]

    NAASSILA, M., HAMMOUMI, S., LEGRAND, E., DURBIN, P., DAOUST, M. Mechanism of action of acamprosate, part I: characterization of spermidine-sensitiv acamprosate binding site in rat brain. Alcoholism, Clinical and Experimental Research, 22, 802-809, 1998. [ Links ]

    O'MALLEY, S.S., JAFFE, A.J., CHANG, G., et al. Naltraxone and Coping skills therapy for alcohol dependence. Archives of General Psychiatry, 49, 881-887, 1992. [ Links ]

    PROJECT MATCH RESEARCH GROUP, Project MATCH: rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcoholism, Clinical and Experimental Research, 17, 1130-1145, 1993. [ Links ]

    SADOCK, B.J., SADOCK, V.A. Kaplan& Sadock's Pocket Handbook of Clinical Psychiatry. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001. [ Links ]

    SELLERS, E.M., TONEATTO, T., ROMACH, M.K., et al. Ondansetron in alcohol abuse and dependence. Alcoholism, Clinical and Experimental Research, 18, 879-885, 1994. [ Links ]

    SEVARINO, K.A., ed. Treatment of Substance Use Disorders. New York, NY: Brunner-Routledge, 2002. [ Links ]

    SWIFT, R.M. Drug therapy for alcohol dependence. The New England Journal of Medicine, 340, 1482-1490, 1999. [ Links ]

    THALLER, V., i sur. Alkohologija (in Croatian). Zagreb: CSCAA, 2002. [ Links ]

    VIRKKUNEN, M., LINNOILA, M. Serotonin in early-onset alcoholism. Recent Developments in Alcoholism, 13, 173-189, 1997. [ Links ]